stockrow
Friday 6 November 2026
Export ASPI’s income statement to Excel — free account
ASP Isotopes Inc.
ASPI Basic Materials Specialty Chemicals
ASP Isotopes Inc.’s revenue for fiscal 2025 (year ended December 2025) was $23.8 million, up 475.5% from fiscal 2024.
- Revenue
- +327.6%
- EPS
- +73.8%
- Free cash flow
- −182.9%
- Total debt
- +162.4%
Quarter to June 2026, against a year earlier
1.95
0.23
+13.37%
Follow ASPI
Alert me
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (87.13%) | (100.67%) | (111.50%) | (152.31%) |
+8 more TTM periods Free account |
|
| (37.30%) | (51.15%) | (59.12%) | (68.10%) | ||
ROIC |
(22.17%) | (18.17%) | (27.24%) | (26.99%) | |
Return on Tangible Assets |
(30.22%) | (37.69%) | (43.72%) | (59.76%) | |
Average Days of Receivables |
35.99 | 32.44 | 506.32 | 2,117.39 | |
Free Cash Flow per Share |
(0.68) | (0.54) | (0.57) | (0.72) | |
Free Cash Flow |
(83.45) | (65.80) | (47.43) | (63.96) | |
Capital Expenditures |
(15.65) | (13.43) | (9.65) | (40.28) | |
| Other line items | |||||
Cash ROIC |
(10.47%) | (7.73%) | (5.99%) | (19.60%) | |
Accounts Receivable Turnover |
1.81 | 17.46 | 1.41 | 0.34 | |
Accounts Payable Turnover |
6.07 | 4.98 | 8.46 | 2.47 | |
Inventory Turnover |
19.59 | 25.92 | 35.13 | 8.86 | |
Average Days of Payables |
82.62 | 113.01 | 68.09 | 193.63 | |
Days of Inventory on Hand |
22.12 | 22.53 | 19.60 | 77.55 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
71.42% | 59.76% | 51.82% | 82.60% | |
Selling, General and Administrative Expense of Revenue |
259.21% | 233.15% | 202.26% | 447.78% | |
Share Based Compensation of Revenue |
62.66% | 71.37% | 70.01% | 171.51% | |
Interest Coverage |
(25.34) | (34.66) | (104.19) | (106.26) | |
Operating CF/Net income |
0.51 | 0.30 | 0.22 | 0.22 | |
Depreciation/Fixed assets |
0.02 | 0.02 | 0.06 | 0.04 | |
Capex/Depreciation |
(2.85) | (2.79) | (5.05) | (37.12) | |
Revenue per Share |
0.25 | 0.22 | 0.29 | 0.09 | |
Operating CF per Share |
(0.55) | (0.43) | (0.46) | (0.27) | |
Capex per Share |
(0.13) | (0.11) | (0.12) | (0.45) | |
Capex to Sales |
0.51 | 0.50 | 0.40 | 4.80 |
Columns are period end dates · fundamentals updated 25 Oct 2026